Eagle Pharmaceuticals (NQ: EGRX )
3.835
+0.015
(+0.39%)
Streaming Delayed Price
Updated: 3:22 PM EDT, Jun 14, 2024
Add to My Watchlist
All News about Eagle Pharmaceuticals![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Eagle Pharmaceuticals Announces Commercial Availability of PEMFEXY™
February 01, 2022
Via Business Wire
![]() ![]() Via Business Wire
![]() ![]() ![]() ![]() ![]()
Eagle Pharmaceuticals Receives FDA Approval for Vasopressin
December 15, 2021
Via Business Wire
![]() ![]() ![]()
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
Via Benzinga
Exposures
Product Safety
![]() ![]()
Eagle Pharmaceuticals, inc (EGRX) Q3 2021 Earnings Call Transcript
November 09, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![]()
Eagle Pharmaceuticals Reports Third Quarter 2021 Results
November 09, 2021
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|